Background Studies indicate that centrally mediated rhythms in sympathetic tone play a prominent role in diurnal cardiovascular variability. Recent evidence from heart transplant recipients, in whom blood pressure does not decline during sleep despite normal variability in plasma norepinephrine, however, suggests that afferent cardiac nervous traffic is necessary for the generation of diurnal variability. This implies that in the presence of an innervated heart excluded from the systemic circulation, blood pressure would still decrease during sleep. To assess this hypothesis, we studied 24-hour blood pressure, heart rate, and neuroendocrine variability in patients with biventricular assist devices in whom the retained native hearts had ceased to pump. Methods and Results Eight patients were free of medication and were studied every 3 hours. Pump rates and output were kept constant throughout the study. Blood pressure showed a T he study of circadian rhythms has A series of observations, however, suggest that the heart itself could play an important role in the establishment of diurnal variations in blood pressure, independently of variations in heart rate: (1) patients with a fixed heart rate still maintain a nocturnal pressure drop14; (2) patients with congestive heart failure show a basically preserved nocturnal reduction in blood pressure,15 whereas the same type of patients, on restoration of normal cardiac function through a denervated heart transplant, do not,7'9 despite normal baroreceptor function, 16 preserved circadian variability in heart rate, and normal variations in plasma norepinephrine7; and (3) a patient without a biological heart but served by an implanted totally artificial heart does not present any circadian variations in pressure.17
These observations thus suggest that a normally innervated heart is a prerequisite for the generation of diurnal variations in blood pressure. If this is a decisive prerequisite, it follows that in a patient whose native heart is excluded from the circulation but remains connected with the central nervous system, a nocturnal drop in pressure would still occur.
This hypothesis was tested in patients in whom the circulation was maintained by a biventricular assist device but whose native heart was left in situ. Blood pressure, heart rate, and neuroendocrine plasma levels were recorded over a 24-hour period of supine rest.
Methods

Study Population
We studied eight patients (four women and four men) who had received a biventricular assist device (BVAD) because of irreversible cardiogenic shock and the unavailability of suitable donor hearts. The mean age of the patients was 38 years (range, 22 to 55 years). Heart failure was due to dilated cardiomyopathy in six and to ischemic cardiac disease in two patients. All patients were clinically stable at the time of study and did not receive cardiovascular medication. Diuretics (two patients) were discontinued 24 hours before the study, during which only low doses of heparin were administered to prevent clotting in the pumps. The patients were studied for an average of 3.5 weeks (range, 1 to 8 weeks) after the BVAD was implanted. The BVAD used was the Berlin Artificial Heart (Berlin Heart Co), a two-chamber artificial heart of the membrane type equipped with four pivoting disk valves with each chamber separately driven by a pneumatic drive unit (Heimes). The BVAD was connected to the heart of the patients via cannulas through which blood was drawn from the right atrium into the right chamber and from there pumped into the main stem of the pulmonary artery. On the left side, blood was drawn from the left atrium and pumped into the ascending aorta via the left chamber. This procedure involves minimal dissection at the atria and thus, combined with longitudinal incisions in the pulmonary artery and the aorta, should leave the vast majority of cardiac nerves intact. The BVAD, placed on top of the abdomen, was connected to the intravascular cannulas via transcutaneous silicone tubings, thus allowing visual inspection of both pump chambers. Repeated echocardiography showed that the aortic valves remained closed in the hearts. Thus, systemic circulation was maintained by the BVAD in all patients. The same was true for the pulmonary circulation in four patients with arrested hearts. In the other four patients, movements of the pulmonary valves could not be visualized with certainty because of interference from the BVAD tubings.
All patients had normal renal function based on levels of serum creatinine (mean±SD, 0.64±0.07 mg/dL; normal range, 0.5 to 1.1 mg/dL) and serum urea (mean, 23 .4±8.7 mg/dL; normal range, 10 to 50 mg/dL). Serum Na+ and Kt were at the lower border of normal (135±2 and 4.0+0.2 meq/L; normal ranges, 138 to 147 and 4.0 to 4.7 meq/L for Na+ and K', respectively). Hematocrit was low in all patients (mean, 0.27±0.07; normal range, 0.37 to 0.52), which is believed to be primarily an effect of the four mechanical valves. The study was approved by the hospital's ethics committee, and all patients gave their consent after thorough information on the aim and risks of the study, which was completed without any early or late adverse effects.
Study Protocol
Patients were studied during 24 hours of supine rest. During this period, pump rate and output were kept constant to avoid pump-induced variations in blood pressure. The rate was 88±6 beats per minute, and left chamber output was 3230±390 mL* min -m 2. Intra-arterial blood pressure was recorded in the left radial artery in four patients by use of optimally vented and calibrated catheter-transducer lines. In the other four, who did not have an arterial line, pressure was measured every third hour with a sphygmomanometer on the left upper arm by a single, trained person not informed about the purpose of the study. To avoid systematic bias, the study began at different times of the day. Central venous pressure (CVP) was measured in half of the patients. Continuous ECG recordings were done in all patients.
Peripheral venous blood drawn every 3 hours into prechilled tubes containing EDTA, heparin, and aprotinin as appropriate was immediately centrifuged for 10 minutes at 3000 rpm and 4°C, and supernatants were stored at -80°C for later analysis. Determinations were done for plasma catecholamines, renin activity (PRA), aldosterone, atrial natriuretic factor (ANF), endothelin 1 and 2, and serum calcitonin gene-related peptide (CGRP), the latter centrifuged and stored after 2 hours of coagulation. Laboratory procedures for determination of catecholamines,7 PRA,1T aldosterone,7 ANF,7 and CGRP19 have been described previously. Endothelin 
Results
Diurnal Changes in Hemodynamics
The patients generally slept from around 10 PM until 7 AM. During this period, all but one patient showed a decline in systolic blood pressure (P<.05) followed by a rise on awakening (Fig 1) . There were no significant variations in diastolic pressure. Mean pressures over 24 hours were 114±7.5 and 58±5 mm Hg for systolic and diastolic pressures, respectively. There were no differences in the magnitude of systolic pressure changes between patients with beating and nonbeating hearts or between patients measured by sphygmomanometry and intra-arterially. Half of the patients had cardiac arrest; heart rate in the other half (fast sinus rhythm) varied in parallel to systolic blood pressure and showed a strong tendency for significant diurnal variability (P=.06). Mean heart rate was 120±20 beats per minute (Fig 1) . CVP was slightly elevated (8.8 ±4.6 mm Hg) and did not vary over time.
Diurnal Changes in Hormone Levels
Both plasma norepinephrine (P<.05) and epinephrine (P<.03) showed a significant diurnal variation, with trough levels around 4 AM (Fig 2) , whereas dopamine did not. Plasma aldosterone also showed a significant increase from 4 AM (P<.05), contrary to the nonsignificant variations in PRA. ANF levels varied significantly during the 24-hour period and peaked around midnight (P<.01, Fig 2) . Endothelin showed a modest but significant peak at 10 AM (P<.05). CGRP did not vary significantly over time.
Compared with our laboratory values from 20 supine, age-matched healthy control subjects (Table) , significantly higher levels in our patients were found for norepinephrine, epinephrine, dopamine, PRA, ANF, and CGRP. Levels of endothelin and aldosterone did 
Discussion
We find it natural to discuss the results of the present study in relation to those obtained from similar groups of patients with end-stage congestive heart failure but treated with a denervated heart transplant. The results thus confirm the hypothesis that in the presence of an innervated heart that is excluded from the systemic circulation, diurnal reduction in blood pressure does occur. This is in contrast to numerous reports on failure of blood pressure to decrease during sleep in patients with denervated cardiac transplants. Since current data suggest that sleep-induced decline in blood pressure primarily reflects a centrally controlled reduction in sympathetic drive to the peripheral vascular tree, as indicated by a nocturnal drop in catecholamines both in the present study with bypassed hearts and in our study of patients with heart transplants and normal control subjects,7 it may be argued that such a control is compromised after cardiac transplantation and institution of immunosuppressive medication. The surgical technique applied for heart transplantation, however, does not affect peripheral vascular innervation; thus, arterial baroreflex sensitivity is normal in heart transplant recipients,16 as well as the vascular response to the cold pressor test,20 ie, results indicating intact auto-13 16 Of interest, however, is the finding of a significant circadian variability in ANF that closely resembles that of normal subjects7,26 but at levels corresponding to those of heart transplant recipients.7 Since ANF in these patients is considerably increased and shows a highly irregular 24-hour profile, this finding adds further evidence to the concept of a neural control of ANF release.
In conclusion, available information from humans with a denervated heart (or without a biological heart) and from patients with a heart no longer active in the circulation but still innervated thus suggests that afferent cardiac traffic to the central nervous system is necessary for establishing diurnal reduction in blood pressure. The results further indicate that neither variations in sympathetic activity (as suggested by significant circadian variations in circulating catecholamines in heart transplant recipients7) nor variations in cardiac output and pump rate (kept constant in the present study) are alone responsible or sufficient for producing nocturnal variations in blood pressure. The results of this study may thus provide further insight into the linkage between diurnal blood pressure variations and the heart, which could be of importance also for the "cause-and-effect" concepts in cardiovascular pathophysiology.
